The Role of Imaging in the Management of Rheumatoid Arthritis Patients: What Does this Mean for My Patients?
Faculty: Orrin M. Troum, M.D. | John V. Crues, III, MD | Sergio Schwartzman, MD
CE credit hour: 1.0
RA management requires frequent monitoring and adjustment of therapy. Therefore, imaging data is an important component of assessing RA severity. New research into the use of ultrasound, MRI, and x-ray show that these imaging techniques have the potential for greater clinical benefits than traditional radiography. This activity aims to provide physicians with the tools necessary to interpret and score imaging data and ultimately, better utilize this information for improving patient outcomes.

Novel Therapies in the Treatment of Rheumatoid Arthritis (Accreditation Expired)
Faculty: Roy Fleischmann, MD | Kathryn Hobbs, MD | Philip Mease, MD | Alan J. Bridges, MD
CME credit hours: 1.5
Recent developments in the treatment of rheumatoid arthritis include the approval of two new biologic agents (abatacept and rituximab), earlier initiation of treatment, and a move toward tight control of therapy with consistent monitoring of disease activity. Data from clinical trials of abatacept and rituximab in patients with rheumatoid arthritis suggest these agents are relatively effective and safe. Our panel of rheumatology experts discusses these issues within the context of recent clinical trial results and the implications for treating patients with rheumatoid arthritis. CME Credit hours: 1.5

The Evolving Management of Bone Disease: Changes on the Horizon (Accreditation Expired)
Faculty: Ethel S. Siris, MD | Jacques P. Brown, MD, FRCP | John A. Kanis, BSc, MB ChB, MD, FRCP, FRCPath | R. Graham Russell, MD, PhD
CME Credit hour: 1.0
The goal of this program is to offer healthcare professionals the opportunity to review the latest clinical data and approaches in the management of metabolic bone disease.

All information content within shall be considered confidential property of ArcMesa Educators, LLC
and should not be disclosed or redistributed to third parties without express permission.